Metabolic basis for low urine pH in type 2 diabetes

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Background and objectives: Type 2 diabetes is associated with excessively low urine pH, which increases the risk for uric acid nephrolithiasis. This study was conducted to assess the metabolic basis responsible for the excessive urinary acidity of individuals with type 2 diabetes. Design, setting, participants, & measurements: Nine non-stone-forming patients who had type 2 diabetes and low urine pH and 16 age- and body mass index-matched non-stone-forming volunteers without type 2 diabetes were maintained on a constant metabolic diet for 7 days, and 24-hour urine was collected on the last 2 days of the diet. Results: Urine dietary markers (potassium, sulfate, phosphorus, and urea nitrogen) were not different between the two groups. Patients with type 2 diabetes exhibited a significantly lower 24-hour urine pH (5.45 ± 0.27 versus 5.90 ± 0.42; P < 0.01) and higher net acid excretion (NAE; 57 ± 12 versus 38 ± 18 mEq/d; P < 0.01) compared with control subjects. The proportion of NAE excreted as ammonium (NH4 +/NAE) was significantly lower in patients with type 2 diabetes than in control subjects (0.70 ± 0.12 versus 0.94 ± 0.36; P < 0.01); however, the greater NAE in patients with type 2 diabetes was not accounted for by the differences in unmeasured urinary anions. Conclusions: The overly acidic urine in patients with type 2 diabetes persists after controlling for dietary factors, body size, and age. The lower pH is due to a combination of greater NAE and lower use of ammonia buffers in patients with diabetes, which predisposes them to uric acid urolithiasis.

Original languageEnglish (US)
Pages (from-to)1277-1281
Number of pages5
JournalClinical Journal of the American Society of Nephrology
Volume5
Issue number7
DOIs
StatePublished - Jul 1 2010

Fingerprint

Type 2 Diabetes Mellitus
Urine
Uric Acid
Dietary Potassium
Diet
Nephrolithiasis
Urolithiasis
Body Size
Ammonium Compounds
Ammonia
Phosphorus
Anions
Urea
Volunteers
Buffers
Body Mass Index
Nitrogen
Acids

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

Metabolic basis for low urine pH in type 2 diabetes. / Maalouf, Naim M.; Cameron, Mary Ann; Moe, Orson W.; Sakhaee, Khashayar.

In: Clinical Journal of the American Society of Nephrology, Vol. 5, No. 7, 01.07.2010, p. 1277-1281.

Research output: Contribution to journalArticle

@article{263d51e08d474ee68cc0e4000a5f64d3,
title = "Metabolic basis for low urine pH in type 2 diabetes",
abstract = "Background and objectives: Type 2 diabetes is associated with excessively low urine pH, which increases the risk for uric acid nephrolithiasis. This study was conducted to assess the metabolic basis responsible for the excessive urinary acidity of individuals with type 2 diabetes. Design, setting, participants, & measurements: Nine non-stone-forming patients who had type 2 diabetes and low urine pH and 16 age- and body mass index-matched non-stone-forming volunteers without type 2 diabetes were maintained on a constant metabolic diet for 7 days, and 24-hour urine was collected on the last 2 days of the diet. Results: Urine dietary markers (potassium, sulfate, phosphorus, and urea nitrogen) were not different between the two groups. Patients with type 2 diabetes exhibited a significantly lower 24-hour urine pH (5.45 ± 0.27 versus 5.90 ± 0.42; P < 0.01) and higher net acid excretion (NAE; 57 ± 12 versus 38 ± 18 mEq/d; P < 0.01) compared with control subjects. The proportion of NAE excreted as ammonium (NH4 +/NAE) was significantly lower in patients with type 2 diabetes than in control subjects (0.70 ± 0.12 versus 0.94 ± 0.36; P < 0.01); however, the greater NAE in patients with type 2 diabetes was not accounted for by the differences in unmeasured urinary anions. Conclusions: The overly acidic urine in patients with type 2 diabetes persists after controlling for dietary factors, body size, and age. The lower pH is due to a combination of greater NAE and lower use of ammonia buffers in patients with diabetes, which predisposes them to uric acid urolithiasis.",
author = "Maalouf, {Naim M.} and Cameron, {Mary Ann} and Moe, {Orson W.} and Khashayar Sakhaee",
year = "2010",
month = "7",
day = "1",
doi = "10.2215/CJN.08331109",
language = "English (US)",
volume = "5",
pages = "1277--1281",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "7",

}

TY - JOUR

T1 - Metabolic basis for low urine pH in type 2 diabetes

AU - Maalouf, Naim M.

AU - Cameron, Mary Ann

AU - Moe, Orson W.

AU - Sakhaee, Khashayar

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Background and objectives: Type 2 diabetes is associated with excessively low urine pH, which increases the risk for uric acid nephrolithiasis. This study was conducted to assess the metabolic basis responsible for the excessive urinary acidity of individuals with type 2 diabetes. Design, setting, participants, & measurements: Nine non-stone-forming patients who had type 2 diabetes and low urine pH and 16 age- and body mass index-matched non-stone-forming volunteers without type 2 diabetes were maintained on a constant metabolic diet for 7 days, and 24-hour urine was collected on the last 2 days of the diet. Results: Urine dietary markers (potassium, sulfate, phosphorus, and urea nitrogen) were not different between the two groups. Patients with type 2 diabetes exhibited a significantly lower 24-hour urine pH (5.45 ± 0.27 versus 5.90 ± 0.42; P < 0.01) and higher net acid excretion (NAE; 57 ± 12 versus 38 ± 18 mEq/d; P < 0.01) compared with control subjects. The proportion of NAE excreted as ammonium (NH4 +/NAE) was significantly lower in patients with type 2 diabetes than in control subjects (0.70 ± 0.12 versus 0.94 ± 0.36; P < 0.01); however, the greater NAE in patients with type 2 diabetes was not accounted for by the differences in unmeasured urinary anions. Conclusions: The overly acidic urine in patients with type 2 diabetes persists after controlling for dietary factors, body size, and age. The lower pH is due to a combination of greater NAE and lower use of ammonia buffers in patients with diabetes, which predisposes them to uric acid urolithiasis.

AB - Background and objectives: Type 2 diabetes is associated with excessively low urine pH, which increases the risk for uric acid nephrolithiasis. This study was conducted to assess the metabolic basis responsible for the excessive urinary acidity of individuals with type 2 diabetes. Design, setting, participants, & measurements: Nine non-stone-forming patients who had type 2 diabetes and low urine pH and 16 age- and body mass index-matched non-stone-forming volunteers without type 2 diabetes were maintained on a constant metabolic diet for 7 days, and 24-hour urine was collected on the last 2 days of the diet. Results: Urine dietary markers (potassium, sulfate, phosphorus, and urea nitrogen) were not different between the two groups. Patients with type 2 diabetes exhibited a significantly lower 24-hour urine pH (5.45 ± 0.27 versus 5.90 ± 0.42; P < 0.01) and higher net acid excretion (NAE; 57 ± 12 versus 38 ± 18 mEq/d; P < 0.01) compared with control subjects. The proportion of NAE excreted as ammonium (NH4 +/NAE) was significantly lower in patients with type 2 diabetes than in control subjects (0.70 ± 0.12 versus 0.94 ± 0.36; P < 0.01); however, the greater NAE in patients with type 2 diabetes was not accounted for by the differences in unmeasured urinary anions. Conclusions: The overly acidic urine in patients with type 2 diabetes persists after controlling for dietary factors, body size, and age. The lower pH is due to a combination of greater NAE and lower use of ammonia buffers in patients with diabetes, which predisposes them to uric acid urolithiasis.

UR - http://www.scopus.com/inward/record.url?scp=77954805668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954805668&partnerID=8YFLogxK

U2 - 10.2215/CJN.08331109

DO - 10.2215/CJN.08331109

M3 - Article

C2 - 20413437

AN - SCOPUS:77954805668

VL - 5

SP - 1277

EP - 1281

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 7

ER -